Efficacy of lifestyle modification combined with GLP-1 receptor agonists on body weight and cardiometabolic biomarkers in individuals with overweight or obesity: a systematic review and meta-analysis.

Chu J, Zhang H, Wu Y, Huang Y, Zhu T, Zhou Z, Wang H

Open source

DOI
10.1016/j.eclinm.2025.103464
Published
2025 Oct
Container
EClinicalMedicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2025.103464,
  title = {Efficacy of lifestyle modification combined with GLP-1 receptor agonists on body weight and cardiometabolic biomarkers in individuals with overweight or obesity: a systematic review and meta-analysis.},
  author = {Chu J and Zhang H and Wu Y and Huang Y and Zhu T and Zhou Z and Wang H},
  year = {2025},
  journal = {EClinicalMedicine},
  doi = {10.1016/j.eclinm.2025.103464},
  url = {https://doi.org/10.1016/j.eclinm.2025.103464}
}

RIS

TY  - JOUR
TI  - Efficacy of lifestyle modification combined with GLP-1 receptor agonists on body weight and cardiometabolic biomarkers in individuals with overweight or obesity: a systematic review and meta-analysis.
AU  - Chu J
AU  - Zhang H
AU  - Wu Y
AU  - Huang Y
AU  - Zhu T
AU  - Zhou Z
AU  - Wang H
PY  - 2025
JO  - EClinicalMedicine
DO  - 10.1016/j.eclinm.2025.103464
UR  - https://doi.org/10.1016/j.eclinm.2025.103464
ER  - 

APA

J, C., H, Z., Y, W., Y, H., T, Z., Z, Z., & H, W. (2025). Efficacy of lifestyle modification combined with GLP-1 receptor agonists on body weight and cardiometabolic biomarkers in individuals with overweight or obesity: a systematic review and meta-analysis.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2025.103464

Source records